Loading...
•
Dec 31, 2022
Organogenesis Q4 2022 Earnings Report
Organogenesis experienced a decrease in revenue and net income compared to the same quarter last year. The company reported net revenue of $115.5 million and a net income of $7.5 million for the fourth quarter of 2022.
Key Takeaways
Organogenesis Holdings Inc. reported a decrease in net revenue and net income for the fourth quarter of 2022 compared to the same period in 2021. Net revenue decreased by 10% to $115.5 million, and net income decreased significantly to $7.5 million.
Net revenue for Q4 2022 was $115.5 million, a 10% decrease compared to Q4 2021.
Net income for Q4 2022 was $7.5 million, a significant decrease from $51.0 million in Q4 2021.
Advanced Wound Care products revenue decreased by 10% to $108.8 million.
Surgical & Sports Medicine products revenue decreased by 6% to $6.7 million.
Organogenesis
Organogenesis
Organogenesis Revenue by Segment
Revenue by Segment
Advanced Wound Care Revenue
CapyFin.comSurgical & Sports Medicine Revenue
CapyFin.com Forward Guidance
For the year ending December 31, 2023, the Company expects net revenue between $450.0 million and $462.0 million.
Positive Outlook
- Net revenue from Surgical & Sports Medicine products between $30.0 million and $34.0 million, an increase of approximately 5% to 19% year-over-year as compared to net revenue of $28.7 million for the year ended December 31, 2022.
Challenges Ahead
- Net revenue between $450.0 million and $462.0 million, remaining flat to an increase of approximately 2% year-over-year, as compared to net revenue of $450.9 million for the year ended December 31, 2022.
- Net revenue from Advanced Wound Care products between $420.0 million and $428.0 million, a decrease of 1% to an increase of approximately 1% year-over-year as compared to net revenue of $422.2 million for the year ended December 31, 2022.
- Net revenue from the sale of PuraPly products between $180.0 million and $200.0 million, representing a decrease of approximately 18% to 26% year-over-year, as compared to net revenue of $242.7 million for the year ended December 31, 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income